First-in-class steroid-toxicity outcome assessments licensed by argenx to support development of novel steroid-sparing ...

Halozyme's strategic acquisition of Evotec and innovative ENHANZE technology present growth opportunities. Click here for a ...

Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced the ...

DelveInsight's 'Systemic Lupus Erythematosus Pipeline Insight 2024' report provides comprehensive global coverage of pipeline ...

Collaboration to leverage Steritas’ STOX Suite in developing innovative treatments for autoimmune diseases.